Pricing

Soleno Therapeutics Inc (SLNO)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO: Anish Bhatnagar
Employees: 30
Web site: soleno.life
203 REDWOOD SHORES PARKWAY, SUITE 500, REDWOOD CITY, CA, 94065
650-213-8444
Stock Split History
DateRatio
2017-10-06 1:5
2022-08-26 1:15
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Soleno Therapeutics is a clinical-stage biopharmaceutical company. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name in May 2017.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available